Boston Financial Management’s West Pharmaceutical WST Stock Holding History

Boston Financial Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$525K	Hold	1,602	–	–	0.02%	237
2024 Q3	$481K	Hold	1,602	–	–	0.01%	244
2024 Q2	$528K	Hold	1,602	–	–	0.02%	234
2024 Q1	$634K	Hold	1,602	–	–	0.02%	230
2023 Q4	$564K	Hold	1,602	–	–	0.02%	230
2023 Q3	$601K	Hold	1,602	–	–	0.02%	213
2023 Q2	$613K	Hold	1,602	–	–	0.02%	222
2023 Q1	$555K	Sell	1,602 -6	-0.4%	-$1.75K	0.02%	218
2022 Q4	$378K	Sell	1,608 -50	-3%	-$11.8K	0.02%	250
2022 Q3	$408K	Buy	1,658 +6	+0.4%	+$1.83K	0.02%	228
2022 Q2	$500K	Hold	1,652	–	–	0.02%	204
2022 Q1	$678K	Buy	1,652 +85	+5%	+$33.3K	0.03%	186
2021 Q4	$735K	Buy	1,567 +50	+3%	+$21.5K	0.03%	165
2021 Q3	$644K	Hold	1,517	–	–	0.03%	169
2021 Q2	$545K	Hold	1,517	–	–	0.02%	169
2021 Q1	$427K	Hold	1,517	–	–	0.02%	183
2020 Q4	$430K	Hold	1,517	–	–	0.02%	177
2020 Q3	$417K	Hold	1,517	–	–	0.02%	177
2020 Q2	$345K	Hold	1,517	–	–	0.02%	190
2020 Q1	$231K	Buy	+1,517	New	+$233K	0.01%	210

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Boston Financial Management's WST Position: Q4 2024 in Review

Boston Financial Management held its West Pharmaceutical (WST) position steady in Q4 2024 at 1,602 shares worth $525K. The position accounts for 0.02% of the portfolio, ranked #237.

Boston Financial Management first reported a position in WST in Q1 2020 and has held it in 20 quarters since. The position peaked at $735K in Q4 2021. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

Boston Financial Management held 1,602 shares of West Pharmaceutical worth $525K as of Q4 2024.
Boston Financial Management left its West Pharmaceutical share count unchanged in Q4 2024.
West Pharmaceutical made up 0.02% of Boston Financial Management's portfolio in Q4 2024, its #237 holding.
Boston Financial Management first reported a position in West Pharmaceutical in Q1 2020 and has held it in 20 quarters since.
Boston Financial Management's West Pharmaceutical position peaked at $735K in Q4 2021.
748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.